<DOC>
	<DOCNO>NCT00000368</DOCNO>
	<brief_summary>Cognitive behavior therapy ( CBT ) without medication use treatment panic disorder ( PD ) . The purpose study 1 ) determine whether nine month maintenance cognitive-behavior therapy ( CBT ) significantly improve likelihood sustained improvement ; 2 ) determine acute acceptability efficacy medication therapy continue CBT alone among patient fail respond sufficiently initial course CBT alone . It find patient PD respond well CBT medication alone combination two . Since combined treatment expensive CBT associate less risk medical toxicity compare medication , CBT alone use first . All patient first receive CBT alone . If patient responds therapy , patient assign randomly ( like toss coin ) 1 2 group . One group continue receive CBT ( maintenance therapy ) 9 month . The group responder receive therapy . If patient respond CBT alone , he/she assign randomly 1 2 different group . One group receive paroxetine ; continue receive CBT long period . The response treatment evaluate see regimen work best treat PD . The study last approximately 3 year . An individual may eligible study he/she panic disorder mild agoraphobia ( fear public place ) least 18 year old .</brief_summary>
	<brief_title>Treatment Panic Disorder : Long Term Strategies</brief_title>
	<detailed_description>To determine maintenance CBT produce sustain improvement among patient panic disorder ( PD ) respond initial course cognitive behavior therapy ( CBT ) alone . For respond sufficiently CBT alone , determine addition pharmacotherapy acceptable improves response among inadequate responder CBT alone . This multicenter study build upon finding prior study compare imipramine , placebo , CBT , combination treatment PD patient mild agoraphobia . That study find response rate high CBT imipramine alone combination . Given add cost combined treatment , therefore seem reasonable begin monotherapy . Further , follow general principle medical practice , would reasonable initiate treatment less invasive cognitive behavioral intervention . It important learn do follow initial treatment . All patient initially receive CBT alone . Patients randomize 1 2 post-acute study , depend response status . Responders randomize maintenance study compare maintenance 9 month continue CBT . Nonresponders randomize study compare paroxetine continue CBT . The following outcome examine : necessity maintenance therapy maintain response ; ability adjunct pharmacotherapy improve response patient respond CBT alone ; possible predictor response relapse ; possible mediator response .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Agoraphobia</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>primary diagnosis Panic disorder without Agoraphobia ( level agoraphobia include ) . current substance abuse dependence , current active suicidal potential ; history psychosis , bipolar disorder ( I II ) cyclothymia ; pending application exist medical disability claim ; significant cognitive impairment , current uncontrolled general medical illness require intervention , psychotherapy direct anxiety panic discontinue first treatment visit , daily use 2mg Xanax equivalent . Exclusion criterion paroxetine study : hypersensitivity Selective Serotonin Reuptake Inhibitors ( SSRI ) , pregnancy , lactation , planned pregnancy course study , contemporaneous medication may interfere interact paroxetine , prior treatment therapeutic dos paroxetine ( 40mg/d 1 mo ) , concurrent treatment antidepressant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Adult</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Long term treatment</keyword>
	<keyword>Remission relapse</keyword>
	<keyword>Male</keyword>
	<keyword>Panic Disorder</keyword>
	<keyword>Paroxetine</keyword>
	<keyword>Serotonin Uptake Inhibitors</keyword>
	<keyword>Panic Disorder -- *therapy</keyword>
	<keyword>Panic Disorder -- drug therapy</keyword>
	<keyword>Paroxetine -- *therapeutic use</keyword>
	<keyword>Serotonin Uptake Inhibitors -- *therapeutic use</keyword>
</DOC>